Inside the UK’s Medical Cannabis Industry – What Needs Change? скачать в хорошем качестве

Inside the UK’s Medical Cannabis Industry – What Needs Change?

The UK legalised Medical Cannabis in 2018, but six years later, the market is stagnant. Why? In this episode, we dive deep into the real reasons behind the failure of the industry, the myths around medical cannabis, and the battle to provide high-quality, consistent medication to patients in need. Tim Kirby (CEO of Releaf) and James Duckenfield (CEO of Glass Pharms) expose the supply chain issues, discuss why UK regulations are holding back patient care, and reveal how they are disrupting the market with science-backed solutions. Let's rethink healTHCare If you’ve ever wondered why medical cannabis is so hard to access in the UK, this is a must-watch. 📌 Topics Covered 00:00 – Intro & Guest Introductions 01:00 – Why the UK’s Medical Cannabis Industry Is Stagnant 04:15 – How Poor Supply Chains Are Hurting Patients 07:30 – Why Many Doctors Avoid Prescribing Medical Cannabis 10:45 – The Shocking Truth About Imported Cannabis 15:20 – How Glass Pharms Raised £26M to Fix the Industry 18:40 – What Makes a Medical Cannabis Product “Safe” 22:10 – The Stigma Around Cannabis & The Fight for Legitimacy 26:00 – How Medical Cannabis Helps Patients with Chronic Pain 30:15 – The Future of Medical Cannabis in the UK 34:50 – Final Thoughts & How to Learn More #medicalcannabis #medicalcannabisclinic #medicalcannabisuk #medicinalcannabis #cannabispodcast #letsrethinkhealthcare